RPS17P10: A Promising Drug Target / Biomarker (G100271071)

Target Name: RPS17P10

NCBI ID: G100271071

RPS17P10

Other Name(s): ribosomal protein S17 pseudogene 10 | RPS17_2_414 | Ribosomal protein S17 pseudogene 10

RPS17P10: A Promising Drug Target / Biomarker

The protein RPS17P10 is a key regulator of the Replication-Cytoskeleton-Protein 17 (RCP17) complex, which is involved in the regulation of DNA replication and cytoskeletal organization. RCP17 is a protein that plays a critical role in ensuring the proper organization and execution of DNA replication in eukaryotic cells. It functions as a scaffold to recruit the necessary components for DNA replication and ensures that the replicated DNA is correctly processed and segregated. The RCP17 complex is composed of various proteins, including RPS17, which is the protein that is targeted in this article.

The RPS17 protein is composed of 170 amino acid residues and has a calculated molecular mass of 19.1 kDa. It is a member of the P1 domain family, which is characterized by a conserved heptadecapeptide repeat and a hydrophobic core. RPS17 is expressed in a variety of tissues, including muscle, heart, and brain, and has been shown to play a role in various cellular processes, including cell growth, differentiation, and stress response.

The Replication-Cytoskeleton-Protein 17 (RCP17) complex is a protein complex that is involved in the regulation of DNA replication in eukaryotic cells. The RCP17 complex is composed of various proteins, including RPS17, which is the protein that is targeted in this article.

The RPS17 complex functions as a scaffold to recruit the necessary components for DNA replication and ensures that the replicated DNA is correctly processed and

Protein Name: Ribosomal Protein S17 Pseudogene 10

The "RPS17P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS17P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets